Skip to content

Achieve Life Sciences ACHV Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

HES
Hess MidstreamHESM
$3M-38.8%
Warrior Met Coal logo
Warrior Met CoalHCC
$374K-7.7%
Main Street Capital logo
Main Street CapitalMAIN
$1.62M+9.8%
Helen Of Troy logo
Helen Of TroyHELE
$405K+31.5%
CorMedix logo
CorMedixCRMD
$99.5K
Orion Group Holdings logo
Orion Group HoldingsORN
$84K-78.7%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's debt issuance cost amortization?
Achieve Life Sciences (ACHV) reported debt issuance cost amortization of $12K in Q1 2026.
How has Achieve Life Sciences's debt issuance cost amortization changed year-over-year?
Achieve Life Sciences's debt issuance cost amortization decreased by 14.3% year-over-year, from $14K to $12K.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).